The treatment of Allergies & Osteoporosis with vitamins

Allergies and Osteoporosis: Mitamins custom make quality formulas for the treatment of Allergies & Osteoporosis with vitamins. A Allergies & Osteoporosis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Allergies and Osteoporosis

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin D
    200
    IU
    50%
    Calcium
    200
    mg
    20%
    Magnesium
    200
    mg
    50%
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
    Lactobacillus acidolphilus
    100
    mg
    *
    Omega - 3 Fatty Acids
    200
    mg
    *
  • Amount Per Serving
    % DV
    MSM
    100
    mg
    *
    Boron
    500
    mcg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    Betaine HCl
    50
    mg
    *
    Thymus
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Allergies and Osteoporosis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
The first reported findings from an international, Phase 3 study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of ustekinumab (CNTO 1275) achieved at least a 75 percent reduction in psoriasis at week 12, the primary endpoint of the study, as measured by the Psoriasis Area and Severity Index (PASI 75).
European Court Of Human Rights Upholds Ruling That Rights Of Polish Woman Allegedly Denied Abortion Were Violated
The European Court of Human Rights on Monday upheld a ruling that ordered the Polish government to award damages to a Polish woman who says that in 2000 she was denied an abortion despite warnings from physicians that she could become blind if she continued the pregnancy, the
This information concerning the support of Allergies and Osteoporosis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments